NDC Package 0019-0953-05 Conray

Iothalamate Meglumine Injection Intravascular - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0019-0953-05
Package Description:
25 VIAL, GLASS in 1 BOX / 50 mL in 1 VIAL, GLASS
Product Code:
Proprietary Name:
Conray
Non-Proprietary Name:
Iothalamate Meglumine
Substance Name:
Iothalamate Meglumine
Usage Information:
Conray is indicated for use in excretory urography, cerebral angiography, peripheral arteriography, venography, arthrography, direct cholangiography, endoscopic retrograde cholangiopancreatography, contrast enhancement of computed tomographic brain images, cranial computerized angiotomography, intravenous digital subtraction angiography and arterial digital subtraction angiography. Conray may also be used for enhancement of computed tomographic scans performed for detection and evaluation of lesions in the liver, pancreas, kidneys, abdominal aorta, mediastinum, abdominal cavity and retroperitoneal space. Continuous or multiple scans separated by intervals of 1 to 3 seconds during the first 30 to 90 seconds post-injection of the contrast medium (dynamic CT scanning) may provide enhancement of diagnostic significance, and may be of benefit in establishing diagnoses of certain lesions in these sites with greater assurance than is possible with CT alone, and in supplying additional features of the lesions. In other cases, the contrast agent may allow visualization of lesions not seen with CT alone, or may help to define suspicious lesions seen with unenhanced CT (see CLINICAL PHARMACOLOGY). Subsets of patients in whom delayed body CT scans might be helpful have not been identified. Inconsistent results have been reported and abnormal and normal tissues may be isodense during the time frame used for delayed CT scanning. The risks of such indiscriminate use of contrast media are well known and such use is not recommended. At present, consistent results have been documented using dynamic CT techniques only.
11-Digit NDC Billing Format:
00019095305
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Product Type:
Human Prescription Drug
Labeler Name:
Liebel-flarsheim Company Llc
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s):
  • Intravascular - Administration within a vessel or vessels.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA013295
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    10-14-2003
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0019-0953-05 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00019095305Q9961Hocm 250-299mg/ml iodine,1ml1 ML5025501250

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0019-0953-1012 BOTTLE, GLASS in 1 BOX / 100 mL in 1 BOTTLE, GLASS
    0019-0953-2325 VIAL, GLASS in 1 BOX / 30 mL in 1 VIAL, GLASS
    0019-0953-5012 BOTTLE, GLASS in 1 BOX / 150 mL in 1 BOTTLE, GLASS

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0019-0953-05?

    The NDC Packaged Code 0019-0953-05 is assigned to a package of 25 vial, glass in 1 box / 50 ml in 1 vial, glass of Conray, a human prescription drug labeled by Liebel-flarsheim Company Llc. The product's dosage form is injection and is administered via intravascular form.

    Is NDC 0019-0953 included in the NDC Directory?

    Yes, Conray with product code 0019-0953 is active and included in the NDC Directory. The product was first marketed by Liebel-flarsheim Company Llc on October 14, 2003 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0019-0953-05?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0019-0953-05?

    The 11-digit format is 00019095305. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20019-0953-055-4-200019-0953-05